LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 201 filers reported holding LEGEND BIOTECH CORP in Q3 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $572,893 | -11.7% | 8,529 | -9.2% | 0.00% | 0.0% |
| Q2 2023 | $648,606 | +66.7% | 9,396 | +16.4% | 0.00% | +50.0% |
| Q1 2023 | $389,135 | +0.1% | 8,070 | +3.2% | 0.00% | 0.0% |
| Q4 2022 | $388,725 | -2.8% | 7,823 | -20.3% | 0.00% | 0.0% |
| Q3 2022 | $400,000 | +4.4% | 9,817 | +40.9% | 0.00% | 0.0% |
| Q2 2022 | $383,000 | -42.1% | 6,968 | -61.8% | 0.00% | -33.3% |
| Q1 2022 | $662,000 | -23.1% | 18,230 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $861,000 | – | 18,230 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 526,072 | $21,595,000 | 11.36% |
| Consonance Capital Management LP | 1,647,497 | $67,630,000 | 8.14% |
| Johnson & Johnson Innovation - JJDC, Inc. | 1,629,173 | $66,878,000 | 6.84% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,342,442 | $55,107,000 | 2.29% |
| Vivo Capital, LLC | 956,702 | $39,273,000 | 1.70% |
| Hudson Bay Capital Management LP | 1,878,374 | $77,107,000 | 0.93% |
| Capital International Sarl | 220,470 | $9,050,000 | 0.78% |
| Capital International, Inc./CA/ | 1,951,845 | $80,123,000 | 0.72% |
| Avidity Partners Management LP | 625,000 | $25,656,000 | 0.69% |
| INDUS CAPITAL PARTNERS, LLC | 94,678 | $3,887,000 | 0.66% |